Macromolecular complexes exhibit reduced diffusion in biological membranes; however, the physiological consequences of this characteristic of plasma membrane domain organization remain elusive. We report that competition between the galectin lattice and oligomerized caveolin-1 microdomains for epidermal growth factor (EGF) receptor (EGFR) recruitment regulates EGFR signaling in tumor cells. In mammary tumor cells deficient for Golgi β1,6N-acetylglucosaminyltransferase V (Mgat5), a reduction in EGFR binding to the galectin lattice allows an increased association with stable caveolin-1 cell surface microdomains that suppresses EGFR signaling. Depletion of caveolin-1 enhances EGFR diffusion, responsiveness to EGF, and relieves Mgat5 deficiency–imposed restrictions on tumor cell growth. In Mgat5+/+ tumor cells, EGFR association with the galectin lattice reduces first-order EGFR diffusion rates and promotes receptor interaction with the actin cytoskeleton. Importantly, EGFR association with the lattice opposes sequestration by caveolin-1, overriding its negative regulation of EGFR diffusion and signaling. Therefore, caveolin-1 is a conditional tumor suppressor whose loss is advantageous when β1,6GlcNAc-branched N-glycans are below a threshold for optimal galectin lattice formation.
Skip Nav Destination
Article navigation
22 October 2007
Article|
October 15 2007
Plasma membrane domain organization regulates EGFR signaling in tumor cells
Patrick Lajoie,
Patrick Lajoie
1Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Search for other works by this author on:
Emily A. Partridge,
Emily A. Partridge
2Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
Search for other works by this author on:
Ginette Guay,
Ginette Guay
3Department of Pathology and Cell Biology, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
Search for other works by this author on:
Jacky G. Goetz,
Jacky G. Goetz
1Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
3Department of Pathology and Cell Biology, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
Search for other works by this author on:
Judy Pawling,
Judy Pawling
2Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
Search for other works by this author on:
Annick Lagana,
Annick Lagana
4Biotechnology Research Institute, National Research Council of Canada, Montreal, Quebec H4P 2R2, Canada
Search for other works by this author on:
Bharat Joshi,
Bharat Joshi
1Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Search for other works by this author on:
James W. Dennis,
James W. Dennis
2Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
5Department of Medical Genetics
6Department of Laboratory Medicine and Pathology, University of Toronto, Toronto, Ontario M5G 1L5, Canada
Search for other works by this author on:
Ivan R. Nabi
Ivan R. Nabi
1Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Search for other works by this author on:
Patrick Lajoie
1Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Emily A. Partridge
2Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
Ginette Guay
3Department of Pathology and Cell Biology, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
Jacky G. Goetz
1Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
3Department of Pathology and Cell Biology, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
Judy Pawling
2Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
Annick Lagana
4Biotechnology Research Institute, National Research Council of Canada, Montreal, Quebec H4P 2R2, Canada
Bharat Joshi
1Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
James W. Dennis
2Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
5Department of Medical Genetics
6Department of Laboratory Medicine and Pathology, University of Toronto, Toronto, Ontario M5G 1L5, Canada
Ivan R. Nabi
1Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Correspondence to Ivan R. Nabi: [email protected]
Abbreviations used in this paper: CT-B, cholera toxin b subunit; EGFR, EGF receptor; EMT, epithelial-mesenchymal transition; LatA, latrunculin A; MMTV, mouse mammary tumor virus; mRFP, monomeric RFP; PyMT, polyoma middle T antigen.
Received:
November 20 2006
Accepted:
September 19 2007
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2007
J Cell Biol (2007) 179 (2): 341–356.
Article history
Received:
November 20 2006
Accepted:
September 19 2007
Connected Content
Citation
Patrick Lajoie, Emily A. Partridge, Ginette Guay, Jacky G. Goetz, Judy Pawling, Annick Lagana, Bharat Joshi, James W. Dennis, Ivan R. Nabi; Plasma membrane domain organization regulates EGFR signaling in tumor cells . J Cell Biol 22 October 2007; 179 (2): 341–356. doi: https://doi.org/10.1083/jcb.200611106
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSee also
Email alerts
Advertisement
Advertisement